Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
5
United Sts Brent Oil Fd Lp Unit
BNO
US Stock MarketDetailed Quotes
Recursion Pharmaceuticals (RXRX)
- 3.370
- -0.150-4.26%
Close May 5 16:00 ET
- 3.370
- 0.0000.00%
Post 20:01 ET
1.79BMarket Cap-2.34P/E (TTM)
3.558High3.320Low13.48MVolume3.520Open3.520Prev Close45.73MTurnover2.69%Turnover RatioLossP/E (Static)529.90MShares7.18052wk High1.58P/B1.69BFloat Cap2.80052wk Low--Dividend TTM502.08MShs Float42.810Historical High--Div Yield TTM6.76%Range %2.800Historical Low3.391Avg Price1Lot Size
Recursion Pharmaceuticals (RXRX) Key Financial Indicators
RXRX Earnings per Share (EPS)
According to the latest financial report of Recursion Pharmaceuticals, the latest earnings per share (TTM) for the company is -0.21. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
RXRX Free Cash Flow (FCF)
Interested in knowing about Recursion Pharmaceuticals's free cash flow? The latest report shows it as -47.32M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
RXRX Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Recursion Pharmaceuticals shows that the company's current ratio is 5.50, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
RXRX Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Recursion Pharmaceuticals, the quick ratio is 5.20, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
RXRX Return on Equity (ROE)
Want to learn more about the financial health of Recursion Pharmaceuticals? The latest ROE figure is -9.93%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
RXRX Return on Assets (ROA)
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Recursion Pharmaceuticals, the total asset return on investment (ROA) is -7.53%.
Currency: USD
Quarterly
Loading...
RXRX Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Recursion Pharmaceuticals's latest financial report to see how their gross margin is doing - currently at 59.62%.
Currency: USD
Quarterly
Loading...
RXRX Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Recursion Pharmaceuticals, the net profit margin is -304.24%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
US President Trump announced on the morning of August 5th, Eastern Time, that based on requests from countries such as Pakistan and signific
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm